Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22
AZD-9291 was approved in Nov
InChi: InChI=1S/C22H44O7S/c23-22(24)10-12-26-14-16-28-18-20-29-19-17-27-15-13-25-11-8-6-4-2-1-3-5-7-9-21-30/h30H
Ponatinib (AP24534) potently inhibits native ABL (IC50: 0
Solubility: DMSO: 35 mg/mL(200
InChiKey: DFULPGUTXZTYKA-UHFFFAOYSA-N
PF-06372865 Catalog No.:M14974-2 AZD-9291 was approved in NovPF 06372865 is an orally active, 2 3 5 subtype selective GABAA positive allosteric modulator (PAM). PF 06372865 is a high affinity ligand at GABAA receptors containing 1 2 3 5 subunits (Kis of 2. 9 nM, 21 nM, 134 nM for 2, 1 PAM, 2 PAM, respectively), with low affinity for 4 6 subunits. PF 06372865 can across the blood brain barrier (BBB). PF 06372865 has anxiolytic activity and has the potential for epilepsy. Product information CAS Number: 1614245